| Phenotype and clinics | retinoblastoma in early childhood: white reflexes in one or both eyes or strabismus usually are the first signs indicating this malignant eye tumour; in most children with the hereditary retinoblastoma, both eyes are affected by multiple tumour foci (bilateral multifocal retinoblastoma) adults (most often relatives of patients with retinoblastoma) may show retinal scars indicating regressed (non-progressive tumours). in addition to retinoblastoma, children with cytogenetic deletions involving 13q14 may show developmental delay and dysmorphic signs. |
| Neoplastic risk | early childhood: formation of retinoblastomas (see genotype-phenotype correlation) adolescence and adulthood: tumours outside the eye (second primary neoplasms): osteosarcoma, melanoma, brain tumours (pinealoma in particular some patients also show multiple benign tumours of adipose tissue (lipoma). |
| Treatment | retinoblastomas can be cured by (depending on size and location): local therapy (photocoagulation, cryotherapy, radiation), combined systemic and local therapy, or enucleation of the eye; surveillance : following the diagnosis of retinoblastoma, repeated examinations under general anesthesia are required for early diagnosis of new tumour foci; up to now, no screening for second primary neoplasms. |
| Prognosis | most often, treatment of retinoblastoma is very effective and, therefore, death from retinoblastoma is rare; however, life span in patients that develop second primary neoplasms is reduced (cumulative mortality at age 40: 6.4% in bilateral patients without radiotherapy, 1.5% in patients with unilateral retinoblastoma). |
| Presenting signs of retinoblastoma. |
| Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd NW 3rd |
| The Journal of pediatrics. 1998 ; 132 (3 Pt 1) : 505-508. |
| PMID 9544909 |
| |
| Molecular etiology of low-penetrance retinoblastoma in two pedigrees. |
| Dryja TP, Rapaport J, McGee TL, Nork TM, Schwartz TL |
| American journal of human genetics. 1993 ; 52 (6) : 1122-1128. |
| PMID 8099255 |
| |
| Mortality from second tumors among long-term survivors of retinoblastoma. |
| Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD Jr |
| Journal of the National Cancer Institute. 1993 ; 85 (14) : 1121-1128. |
| PMID 8320741 |
| |
| Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism. |
| Fleischman RA, Gallardo T, Mi X |
| The Journal of investigative dermatology. 1996 ; 107 (5) : 703-706. |
| PMID 8875953 |
| |
| A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. |
| Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP |
| Nature. 1986 ; 323 (6089) : 643-646. |
| PMID 2877398 |
| |
| Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. |
| Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, Ling V, Chan HS |
| Archives of ophthalmology. 1996 ; 114 (11) : 1321-1328. |
| PMID 8906022 |
| |
| Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? |
| Gallie BL, Ellsworth RM, Abramson DH, Phillips RA |
| British journal of cancer. 1982 ; 45 (4) : 513-521. |
| PMID 7073943 |
| |
| A simplified scheme for genetic counseling in retinoblastoma. |
| Musarella MA, Gallie BL |
| Journal of pediatric ophthalmology and strabismus. 1987 ; 24 (3) : 124-125. |
| PMID 3598831 |
| |
| Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. |
| Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP |
| Nature. 1991 ; 353 (6339) : 83-86. |
| PMID 1881452 |
| |
| Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. |
| Sippel KC, Fraioli RE, Smith GD, Schalkoff ME, Sutherland J, Gallie BL, Dryja TP |
| American journal of human genetics. 1998 ; 62 (3) : 610-619. |
| PMID 9497263 |
| |
| Complete genomic sequence of the human retinoblastoma susceptibility gene. |
| Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TP |
| Genomics. 1993 ; 17 (3) : 535-543. |
| PMID 7902321 |
| |